Mikhail Blagosklonny Works to Fight Cancer . . . and Aging.

Rapamycin is a compound that is used to prevent organ transplant rejection and to coat coronary stents. But according to Dr. Mikhail Blagosklonny, it can serve other purposes. The professor of oncology at Roswell Park Cancer Institute has come up with a hypothesis that rapamycin can be used not only to treat cancer, but to help slow the aging process.

Blagosklonny believes that TOR Signaling, which utilizes rapamycin, can be used in both treatments. The mTOR pathway helps regulate metabolism and physiology. Much of Blagosklonny’s research involves molecular and cellular biology as it relates to protecting healthy cells from damage by cancer, and slowing the aging process and halting age related diseases.

Along with his research work, Mikhail Blagosklonny published numerous papers in peer reviewed journals going back to 2000. Topics he has written about include TOR signaling, selective cancer therapy, and diabetic complications. He is also the editor-in-chief of three different medical related periodicals. They are Aging, Cell Cycle, and Oncotarget. View Mikhail’s profile on Loop

Blagosklonny came to the Roswell Park Cancer Institute in Buffalo, New York in 2009. His main job is to develop various anti-cancer strategies. Some of those strategies involve trying to prevent cancer by slowing the aging process.

Dr. Mikhail Blagosklonny received his PhD from First Pavlov State Medical University of St. Petersburg in Russia. Coming to the United States, he worked as a professor of medicine at New York Medical Center and a senior scientist at Albany’s Ordway Research Institute before going on to Roswell Park. Read more  https://scholar.google.com/citations?user=REO9YogAAAAJ&hl=en

InnovaCare Health and Its Management

The main office of InnovaCare Health is located in Fort Lee, New Jersey. The firm provides services in the healthcare sector including physician services. The mission of InnovaCare Health is to bring revolution to the healthcare management and to eliminate the problems that people face in the current era of healthcare. The vision of InnovaCare Health is to foster a healthy relationship between the patient and the provider. The subsidiaries of InnovaCare Health support the organization. It comes up with healthcare plans that are affordable, coordinated, new, and quality driven. The patient comes first at InnovaCare. Their ultimate goal is to deliver quality medical care.

InnovaCare Health has been able to put a robust and efficient leadership team together. Dr. Rick Shinto heads the team. He is also known as Rick Shinto. Rick Shinto has more than 20 years of experience in the medical field. He serves as the current president and chief executive officer. Rick Shinto worked there as the CEO and President before Aveta Inc. was sold in 2012. Shinto was also part of the management team. He is in charge of the health plans of InnovaCare Health in Puerto Rico. Rick Shinto is a former employee of NAMM California. He was also the chief medical officer and the COO (chief operating officer) at Medical Pathways Management Company.

Rick Shinto moved to Cal Optima Health Plan, Orange County after working for one year at Medical Pathways Management Company. He worked as the company’s chief medical officer. Dr. Shinto is an author who writes on topics of clinical medicine and healthcare. He has a BS that he acquired from the University of California, a medical degree from the State University of New York, and an MBA that he got from the University of Redlands. The current chief administrative officer of InnovaCare Health is Penelope Kokkinides. She worked at the firm since 2015. Penelope has been working in the healthcare sector for approximately 20 years. She has lots of experience.

Read this article at openminds.com.

Penelope Kokkinides understands how to develop clinical programs and processes in managed health care. Penelope was the executive vice president at Centerlight HealthCare before joining InnovaCare Health. She also served at Touchstone Health as the chief operating officer. Penelope worked at AmeriChoice as the Corporate vice president of disease management and care management. She attended Binghamton University where she got her Bachelor’s degree in Biological Sciences and Classical Languages. Penelope also has a Master’s degree in Public Health. She acquired it from the school of Public Health at Columbia University.

Read more about Rick on Businesswire.